Page last updated: 2024-08-24

brequinar and Graft vs Host Disease

brequinar has been researched along with Graft vs Host Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kahan, BD; Stepkowski, SM; Wang, M1
Chou, TC; Kahan, BD; Qu, X; Stepkowski, SM; Wang, M1

Other Studies

2 other study(ies) available for brequinar and Graft vs Host Disease

ArticleYear
Donor pretreatment with anti-T-cell receptor monoclonal antibodies prevents graft-vs-host disease in brequinar-treated small bowel allograft recipients.
    Transplantation proceedings, 1995, Volume: 27, Issue:1

    Topics: Animals; Antibodies, Monoclonal; Biphenyl Compounds; Graft Survival; Graft vs Host Disease; Immunosuppressive Agents; Intestine, Small; Rats; Rats, Inbred BN; Rats, Inbred Lew; Receptors, Antigen, T-Cell, alpha-beta; Transplantation, Homologous

1995
Beneficial effect of graft perfusion with anti-T cell receptor monoclonal antibodies on survival of small bowel allografts in rat recipients treated with brequinar alone or in combination with cyclosporine and sirolimus.
    Transplantation, 1996, Feb-15, Volume: 61, Issue:3

    Topics: Animals; Antibodies, Monoclonal; Antilymphocyte Serum; Biphenyl Compounds; Cyclosporine; Graft Survival; Graft vs Host Disease; Graft vs Host Reaction; Host vs Graft Reaction; Immune Tolerance; Immunosuppressive Agents; Intestine, Small; Male; Perfusion; Polyenes; Rats; Rats, Inbred ACI; Rats, Inbred BN; Rats, Inbred Lew; Receptors, Antigen, T-Cell, alpha-beta; Sirolimus; Time Factors; Transplantation, Homologous

1996